September 30, 2013
Gliknik Enters Into Licensing Agreement With Pfizer for Drug Candidate Targeting Autoimmune Diseases
GL-2045 is Gliknik’s Lead Recombinant Stradomer™ Designed to Improve on Pooled Human Intravenous Immunoglobulin Gliknik…